Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2007
02/20/2007US7179602 Preparing a reaction mixture, dissociating the sample DNA to create single stranded templates, annealing primers to primer sites, extending the annealed primers to generate a series of fluorescently-labeled dideoxynucleic acid fragments, heating, repeating, determining nucleotide sequence of sample DNA
02/20/2007US7179601 Methods of identifying plant disease-resistance genes
02/20/2007US7179600 Oligonucleotide chip composition and a method for analyzing a hepatitis C virus genotype using the composition
02/20/2007US7179599 Mobilization of viral genomes from T-DNA using site-specific recombination systems
02/20/2007US7179598 Methods and kits for detecting chromosome translocations; diagnosing cancer
02/20/2007US7179597 Genetic diagnosis for QT prolongation related adverse drug reactions
02/20/2007US7179596 Solid support comprising biopolymers for detection of biological/chemical warfare agents
02/20/2007US7179595 non-single-chain antigen-binding units that is stabilized by leucine zipper sequences; useful for generating and screening for non-single-chain antigen-binding units that remain the binding capabilities to their respective antigens within a cell of major diagnostic and/or therapeutic potential
02/20/2007US7179594 Method for distinguishing 5-position methylation changes of cytosine bases and cytosine-to-thymine mutations and for detecting single nucleotide polymorphisms (SNPs) or point mutations in genomic DNA
02/20/2007US7179593 Estrogen receptor site-specific ribozymes and uses thereof for estrogen dependent tumors
02/20/2007US7179592 Size-exclusion-based extraction of affinity ligands and active compounds from natural samples
02/20/2007US7179591 Biosynthesis
02/20/2007US7179590 High temperature reverse transcription using mutant DNA polymerases
02/20/2007US7179589 Single stranded DNA sequence hybridizes an oligonucleotide or DNA analogue and then complexes with a marker; output signals are measured for formation and dissociation indications
02/20/2007US7179588 Assay for the detection of paclitaxel resistant cells in human tumors
02/20/2007US7179470 Hepatitis-C virus testing
02/20/2007US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
02/20/2007US7179447 Type I interferon-producing cells and uses thereof
02/20/2007US7179423 Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system
02/20/2007CA2351634C Thermostable enzyme promoting the fidelity of thermostable dna polymerases- for improvement of nucleic acid synthesis and amplification in vitro
02/20/2007CA2289979C Methods of modulating immune coagulation
02/20/2007CA2286680C Detachable-element assay device
02/20/2007CA2133956C Dna sequencing method
02/18/2007CA2556456A1 Method of regulation of bacterial persister status
02/15/2007WO2007019570A2 Selective dehybridization using electrochemically-generated reagent on an electrode microarray
02/15/2007WO2007019527A2 Optical sensor and methods for measuring molecular binding interactions
02/15/2007WO2007019492A2 Methods for detection of a nucleic acid by sequential amplification
02/15/2007WO2007019462A2 System and method for the identification and quantification of a biological sample suspended in a liquid
02/15/2007WO2007019422A2 Signal pattern compositions and methods
02/15/2007WO2007019415A2 Specific bacterial inclusions in bone marrow cells indicate systematic lupus erythematosus, and treatment for lupus
02/15/2007WO2007019410A2 Mammalian obestatin receptors
02/15/2007WO2007019395A1 Method for distinguishing electrochemical sensors
02/15/2007WO2007019312A2 Methods for characterizing and treating cognitive impairment in aging and disease
02/15/2007WO2007019283A2 Identification of 5-lipoxygenase effects on obesity and insulin resistance
02/15/2007WO2007019119A2 Rna complexes methods of their production and sensors and analytical methods involving same
02/15/2007WO2007019103A2 Method and apparatus for sorting particles with a mems device
02/15/2007WO2007019094A2 Modified influenza virus for monitoring and improving vaccine efficiency
02/15/2007WO2007018760A2 Preparation of plastic supports for biochips
02/15/2007WO2007018734A2 Q-melt for polymorphism detection
02/15/2007WO2007018656A2 Cgh array quality assessement
02/15/2007WO2007018602A1 Isolation of cpg islands by thermal segregation and enzymatic selection-amplification method
02/15/2007WO2007018601A1 Compositions and methods for processing and amplification of dna, including using multiple enzymes in a single reaction
02/15/2007WO2007018574A2 Diagnostic assay for rickettsia prowazekii disease by detection of responsive gene expression
02/15/2007WO2007018563A2 Probe arrays for detecting multiple strains of different species
02/15/2007WO2007018511A1 Lupus anticoagulant testing
02/15/2007WO2007018318A1 Method for gene expression specific to cerebellar astrocyte and/or basket cell
02/15/2007WO2007018309A1 Method for evaluating compound using molecule on the rb pathway as index and molecular diagnostic method
02/15/2007WO2007018307A1 Phosphoadenylyl sulfate reductase gene and use thereof
02/15/2007WO2007018282A1 Method of determining a biospecies
02/15/2007WO2007018257A1 Method of detecting large bowel cancer marker
02/15/2007WO2007018238A1 Method of screening apoptosis accelerating compound or anti-apoptotic compound and method of determining malignancy of neurodegenerative disease
02/15/2007WO2007018236A1 Screening method for compound inhibiting development or progression of familial amyotrophic lateral sclerosis and diagnostic method for familial amyotrophic lateral sclerosis
02/15/2007WO2007018225A1 Method of staining substance having phosphate group
02/15/2007WO2007018182A1 Cancer-like mutant
02/15/2007WO2007018169A1 Method for detection of inosine-containing site in rna
02/15/2007WO2007018143A1 Use of gene which varies in amount of expression during the course of transition from precancer to cancer
02/15/2007WO2007017699A2 In vitro diagnostic kit for identification of human papillomavirus in clinical samples
02/15/2007WO2007017684A2 Ph tolerant luciferase
02/15/2007WO2007017601A1 Bacterial culture medium in a minimum inorganic medium, comprising gentisate and/or one of the precursors thereof, and use of 3-hydroxybenzoate in one such medium
02/15/2007WO2007017186A1 Herbicide tolerant cotton plants and methods for identifying same
02/15/2007WO2007017065A2 Angiogenesis inhibition based upon icam 1 or junb expression levels
02/15/2007WO2007016975A1 Kinase and phosphatase assays based on fret
02/15/2007WO2007016929A1 Method for preparation of dna ladder using pcr and its optimization by numerical modeling thereof
02/15/2007WO2006138377A9 Compound combinations for inhibiting cell division and methods for their identification and use
02/15/2007WO2006128463A3 Compositions and methods for predicting outcome of treatment
02/15/2007WO2006128163A3 Transgenic alzheimer's mouse model vectors and uses thereof
02/15/2007WO2006126040A8 Bacterial and bacterial associated mirnas and uses thereof
02/15/2007WO2006125830A3 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases
02/15/2007WO2006124726A3 Novel biotinylated compositions
02/15/2007WO2006121888A3 Methods of nucleic acid target capture
02/15/2007WO2006119280A3 Lyophilized pellets
02/15/2007WO2006114245A3 Identification of human gene sequences of cancer antigens expressed in metastatic carcinoma and involved in metastasis formation, and their use in cancer diagnosis, prognosis and therapy
02/15/2007WO2006112867A3 Microarray gene expression profiling in classes of papillary renal cell carcinoma
02/15/2007WO2006111743A3 Identifying lantibiotic gene clusters and novel lantibiotic genes
02/15/2007WO2006108599A3 Ghrelin binding nucleic acids
02/15/2007WO2006106316A3 Polynucleotide primers
02/15/2007WO2006094836A3 Specific dnas for epigenetic characterisation of cells and tissues
02/15/2007WO2006090136A3 Genetic screening of animals
02/15/2007WO2006085972A9 Compositions and processes for the extraction and detection of microbial atp
02/15/2007WO2006084109A3 Salivary protease assays for identifying increased risk of preterm delivery induced by premature rupture of fetal membranes
02/15/2007WO2006078503A3 Compositions for modulation of parp and methods for screening for same
02/15/2007WO2006076046A3 Branched and multi-chain nucleic acid switches for sensing and screening
02/15/2007WO2006072782A3 Tetracyanoquinodimethane composite material and use in electrodes
02/15/2007WO2006032021A3 Identification of gene associated with reading disability and uses therefor
02/15/2007WO2006025850A3 Method of detecting coliform bacteria from reflected light
02/15/2007WO2006015114A3 Imaging methods and apparatus having extended dynamic range
02/15/2007WO2006014509A3 Quantitative pcr data analysis system (qdas)
02/15/2007WO2006012518A3 METHOD AND COMPOSITIONS INVOLVING PROTEIN KINASE-δ
02/15/2007WO2005121378A3 Methods and compositions for vaccination
02/15/2007WO2005116264A3 A blood test to monitor the genetic changes of progressive cancer using immunomagnetic enrichment and fluorescence in situ hybridization (fish)
02/15/2007WO2005067583A3 Immunoliposome-nucleic acid amplication (ilnaa) assay
02/15/2007WO2005003289A8 Ap1 amine oxidase variants
02/15/2007WO2004023270A8 Crystal structure of angiotensin-converting enzyme-related carboxypeptidase
02/15/2007US20070039072 Functional and hyperfunctional siRNA
02/15/2007US20070039070 transforming plant cells with a DNA construct comprising nucleic acid sequences, Eucalyptus caffeic acid 3-O-methyltransferase (COMT) promoters and nucleic acid sequence that code for polypeptides, then culturing said transformed plant cells, to producing transgenic plants
02/15/2007US20070039067 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
02/15/2007US20070039064 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
02/15/2007US20070039063 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy
02/15/2007US20070039062 Goodpasture's syndrome model mouse
02/15/2007US20070037798 Thiolactones